Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash on Hand and in U.S. Banks
QFRTCASH385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
65,271.00
Year-over-Year Change
-3.02%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the total cash reserves held by U.S. pharmaceutical and medicine corporations in domestic banks. It provides critical insight into the financial liquidity and strategic cash management of a key sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the aggregate liquid financial resources available to pharmaceutical companies, reflecting their financial health and potential for investment, research, or strategic acquisitions. Economists and investors use this data to assess the sector's financial resilience and potential economic impact.
Methodology
Data is collected through quarterly financial reporting by corporations in the pharmaceutical and medicine manufacturing sector, compiled and standardized by the U.S. Federal Reserve.
Historical Context
This trend is used to analyze corporate financial strategies, potential investment cycles, and sectoral economic performance in the healthcare and pharmaceutical industries.
Key Facts
- Represents total liquid assets for U.S. pharmaceutical corporations
- Quarterly data provides snapshot of sector's financial health
- Indicates potential for R&D investment and strategic spending
FAQs
Q: What does this trend indicate about pharmaceutical companies?
A: It shows the total cash reserves available to pharmaceutical firms, reflecting their financial strength and potential for investment or expansion.
Q: How often is this data updated?
A: The data is typically updated on a quarterly basis, providing a current view of the sector's financial position.
Q: Why are cash reserves important for pharmaceutical companies?
A: Cash reserves enable companies to fund research and development, make strategic acquisitions, and maintain financial stability during market fluctuations.
Q: How do investors use this information?
A: Investors analyze these cash reserves to assess a company's financial health, potential for growth, and ability to weather economic challenges.
Q: What limitations exist in this data?
A: The trend provides an aggregate view and may not capture individual company variations or specific financial strategies.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Accumulated Depreciation, Depletion, and Amortization
QFR218TRAUSNO
Quarterly Financial Report: U.S. Corporations: All Information: All Other Current Assets
QFR215INFUSNO
Quarterly Financial Report: U.S. Corporations: All Other Information: Retained Earnings at Beginning of Quarter
QFRD119519USNO
Quarterly Financial Report: U.S. Corporations: Nonferrous Metals: Total Assets
QFR223381USNO
Quarterly Financial Report: U.S. Corporations: All Other Information: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102519USNO
Quarterly Financial Report: U.S. Corporations: Iron, Steel, and Ferroalloys: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326371USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Cash on Hand and in U.S. Banks [QFRTCASH385USNO], retrieved from FRED.
Last Checked: 8/1/2025